Sign inJoin waitlistJoin the waitlist

Katy Tsai

Assoc Prof Clinical Medicine · University of California (San Francisco) School of Medicine

Credentials: · · ·

History

University of California-San Francisco
2014–2016
Internal Medicine
University of North Carolina School of Medicine
2011–2013
Alpert Medical School
2006–2010
Brown University

Research

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab
Annals of Oncology · 2017 · 644 citations
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC
Cancer Immunology Research · 2017 · 505 citations
Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma
Journal of Clinical Investigation · 2016 · 433 citations

Adil Daud
27 papers
Alain Algazi
12 papers
Douglas Johnson
10 papers
Michael Rosenblum
8 papers
Bartosz Chmielowski
7 papers
Ryan Sullivan
7 papers
Sunandana Chandra
7 papers
ZE
Zeynep Eroglu
7 papers · 2 as a fellow
AS
Alexander Shoushtari
6 papers · 3 as a fellow
Shailender Bhatia
6 papers
Antoni Ribas
5 papers
April Salama
5 papers

Clinical trials

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Principal investigator · Recruiting · Phase 2
University of California, San Francisco
2021–2028
Trial of pIL-12/MK-3475 in Metastatic Melanoma
Principal investigator · Completed · Phase 2
University of California, San Francisco
2015–2020
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
Site PI · Recruiting · Phase 3
Replimune, Inc.
2024–2031
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
Site PI · Recruiting · Phase 1, Phase 2
Georgiamune Inc
2024–2027